SCHEMBL13537632

SCHEMBL13537632

CCN1C(=O)CS/C1=C(/N)C(=O)NCCF

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ ATM Q13315 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ GAA P10253 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ GFER P55789 1/20 0.31
▸ HTT P42858 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GSK3A P49840 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ RAB9A P51151 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13537363 0.88 MEN1 (0.38) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL13537262 0.86 MEN1 (0.39) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL13537263 0.83 MAPT (0.36) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL13537259 0.83 MEN1 (0.38) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL3354063 0.81 ALDH1A1 (0.46) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL13488669 0.81 ALDH1A1 (0.46) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL13537426 0.81 MEN1 (0.34) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL13537540 0.78 KMT2A (0.43) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL14608231 0.76 HTT (0.44) ALDH1A1MEN1KMT2AMAPTHSD17B10
SCHEMBL13537424 0.75 MEN1 (0.36) ALDH1A1L3MBTL1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 — — EP disclosed
Send feedback